Polymerase chain reaction Market Size Worth USD 19.24 Billion in 2032 | Emergen Research

Vancouver, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global polymerase chain reaction (PCR) market size was USD 8.50 Billion in 2022 and is expected to register a revenue CAGR of 8.5% during the forecast period. This growth is attributed to the increasing prevalence of clinical diagnostic applications, rapid technological advancements, and a rising demand for personalized and precision medicines worldwide.

PCR, a fundamental tool for amplifying small segments of the genome, gained prominence in 2020 as a primary method for detecting the SARS-CoV-2 virus. Recent trends highlight the rapid growth of Digital PCR (dPCR) and quantitative real-time PCR, with Thermo Fisher Scientific launching a cutting-edge dPCR research solution in March 2023, offering enhanced automation and reduced operator time.

To access the free sample copy of Polymerase chain reaction visit @ https://www.emergenresearch.com/request-sample/2490

Real-time PCR, a versatile method in molecular biology and diagnostics, is witnessing a surge in partnerships among major companies for the detection and diagnosis of infectious diseases. Notably, Trivitron Healthcare's development of a Real-time PCR-based kit for Monkeypox virus detection showcases the technology's versatility and efficiency.

Market Drivers:

The major factors propelling the market's revenue growth include the expanding scope of clinical diagnostic applications and the escalating demand for personalized and precision medicines. The market also benefits from the substantial government funding in genomic research and development. For example, the UK Government's announcement of 22 projects, including one from Oxford University focusing on personalized healthcare using Artificial Intelligence, underscores the ongoing support for such initiatives.

Market Trends:

A notable trend shaping the market is the rapid technological advancement in PCR technology. Collaborations for robot-based PCR machines and innovations like Blocker Displacement Amplification technology demonstrate the industry's commitment to staying at the forefront. Kawasaki Heavy Industries' collaboration for a mobile, automated PCR testing system and licensing agreements between Bio-Rad and NuProbe for digital PCR methods exemplify the market's dynamic technological landscape.

Market Segment Insights:

PCR Product Type:

• Instruments Segment: Accounted for the largest revenue share in 2022. The introduction of advanced digital PCR instruments, as exemplified by The Central Science Laboratory's announcement of a new digital PCR instrument, is driving significant revenue growth.
• Reagents and Consumables Segment: Expected to register a steady revenue CAGR. Collaborations between companies like Scientific Laboratory Supplies Ltd and Novacyt highlight the importance of investing in PCR reagents and master mixes to enhance workflow product portfolios.

Don't Miss Out! Grab Your Discounted Copy Today @ https://www.emergenresearch.com/request-discount/2490

PCR Application:

• Clinical Diagnostics Segment: Dominated the market in 2022, with applications ranging from infectious disease detection to prenatal genetic testing and oncology research.
• Industrial Application Segment: Expected to register the highest revenue CAGR. PCR test kits for various purposes, including cancer and infectious disease testing, are commercially launched, and collaborations between major biopharma industries drive segment growth.

Regional Insights:

North America: Accounted for the second-largest revenue share in 2022, driven by a growing number of clinical trial studies and a rising prevalence of cancer and metabolic disorders.

Europe: Showcased a significantly large revenue share in 2022, with key strategic initiatives and partnerships between major market companies contributing to market growth.

Asia Pacific: Expected to register a robust revenue CAGR, supported by growing government regulations, emerging startups, and major key strategic initiatives, including nanotechnology research programs for portable PCR platforms.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2490

Polymerase Chain Reaction Report Summary  

Polymerase Chain Reaction Top Companies and Competitive Landscape 

The global polymerase chain reaction market is fairly fragmented, with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective polymerase chain reaction solutions.

Some major players included in the global polymerase chain reaction market report are:

• Eppendorf SE
• Abbott
• Thermo Fischer Scientific Inc.
• Agilent Technologies, Inc.
• bioMerieux SA
• Bio-Rad Laboratories, Inc
• Merck KGaA
• Hoffmann-La Roche Ltd
• Becton Dickinson and Company
• PerkinElmer Inc.
• Promega Corporation.
• Siemens Healthcare GmbH
• Danaher
• QIAGEN
• Takara Bio Inc
• QuantuMDx Group Ltd.
• Standard BioTools Inc.
• Stilla
• MatMaCorp.
• PCR Biosystems
• JN Medsys.
• Hygiena LLC

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/polymerase-chain-reaction-market  

Polymerase Chain Reaction Latest Industry News

• On 17 February 2023, Thermo Fisher Scientific announced that real-time PCR kits for the identification of infectious illnesses would be available in India. The Central Drugs Standard Control Organization (CDSCO) has granted licensing rights for the Applied BiosystemsTM TaqPathTM PCR kits for infectious diseases, including M. Tuberculosis complex (MTB), Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Multi-Drug Resistant Tuberculosis (MTB MDR). These kits will be produced in India in collaboration with Mylab Discovery Solutions, the top healthcare company in India.
• On 10 March 2023, GeneProof, a leader in molecular diagnostics, announced the introduction of six additional IVDR-certified PCR kits to its extensive line. The recently added IVDR kits are targeted at the diagnosis of Sexually Transmitted Diseases (STDs). They comprise Multiplex CNMX, which is designed to detect Sexually Transmitted Diseases (STDs), Mycoplasma genitalium, and Neisseria gonorrhoeae; Duplex MGH, which is designed to detect STDs, Mycoplasma genitalium/hominis; Multiplex MUPX, which is designed to detect STDs, Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum; and Singleplex Kits, which are designed to detect STDs, STIs respectively.

For the purpose of this report, Emergen Research has segmented the global polymerase chain reaction market on the basis of product type, indication, application, end-use, and region:

• Product Type Outlook (Revenue, USD Billion; 2019-2032)
  • • • Instruments
        • Standard PCR
        • Digital PCR
        • Real-time PCR
      • Reagent and Consumables
      • Software and Services
• Indication Outlook (Revenue, USD Billion; 2019-2032)
  • • • Oncology
      • Infectious Disease
      • Genetic Disorder
      • Other
• Application Outlook (Revenue, USD Billion; 2019-2032)
  • • • Life Science Research
      • Industrial Application
      • Clinical Diagnostics
        • Pathology testing
        • Blood Testing
        • Oncology Testing
      • Non-Medical
        • Food
        • Other Applications
• End-Use Outlook (Revenue, USD Billion; 2019-2032)
  • • • Hospitals and Clinical Diagnostic Laboratories
      • Academic Institutes and Research Organizations
      • Biotechnology and Pharmaceutical Industries
      • Forensic Laboratories

• • Other End-Users

• Regional Outlook (Revenue, USD Billion; 2019-2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. France
    3. U.K.
    4. Italy
    5. Spain
    6. Benelux
    7. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Turkey
    5. Rest of MEA

Curated Reports You Shouldn't Miss: Dive In Now!

Electric Vehicle Battery Market Size, Share, Trends, By Battery Type (Lead-acid, Lithium-ion, Others), By Vehicle Type (Commercial, Passenger), and By Propulsion (Plug-In Hybrid, Battery), Forecasts to 2027

Agriculture Surfactants Market By Type (Non-ionic, Anionic, Cationic, Amphoteric), By Substrate (Synthetic, Bio-based), By Application (Insecticide, Herbicide, Fungicide), Forecasts to 2027

Sustainable Packaging Market Size, Share, Trends, By Materials (Plastic, Paper & Paperboard, Glass, Metal), By Packaging Type, By End Users, Forecasts to 2027

Battery Materials Market Analysis By Battery Type (Lead-Acid, Lithium-Ion, Others), By Material Type (Metal & Metal Oxide, Other Chemical Compounds), By Application (Consumer Electronics, Automotive, Grid Storage, Others), By Region, Forecasts to 2027

Lithium Ion Battery Recycling Market, By Battery Chemistry (Lithium-Iron Phosphate, Lithium-Manganese Oxide, Lithium-Titanate Oxide, and Others), By Source, By Recycling Process, By End-Use, and By Region Forecast to 2030

Air Purifier Market By Technology (HEPA, Activated Carbon, Ionic Filters, Others), By Applications (Commercial, Residential, Industrial, Others) and By Regions Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights